VN July 2025

Vetnews | Julie 2025 20 « BACK TO CONTENTS Toward an integrative molecular approach to wildlife disease Alexandra L. DeCandia, Andrew P. Dobson, and Bridgett M. vonHoldt Department of Ecology and Evolutionary Biology, Princeton University, 106A Guyot Hall, Princeton, NJ 08544, U.S.A. Introduction Integrative molecular approaches have yielded novel insights into human disease at a variety of scales. Independent and concurrent analysis of genetic, epigenetic, and commensal microbial diversity has elucidated proximate and ultimate drivers of disease state and transformed the understanding of pathogenesis, transmission, and treatment (Pacis et al. 2014; Hand 2016). Similar analyses have only recently appeared within the context of wildlife disease and conservation science. We argue that the adoption of diverse molecular methods in wildlife disease will provide a more thorough appreciation of mechanisms that underlie host disease states and ultimately translate into more effective population monitoring, management, and conservation. Wildlife disease can pose significant threats to human health, agricultural investment, and biodiversity conservation through the emergence of zoonoses, spillover to domestic livestock, and epizootic outbreaks (Daszak et al. 2000). Initially, theoretical models suggested that disease-mediated declines would halt transmission before host extinction could occur (Anderson & May 1979). Although this is true for many pathogens with density-dependent transmission, these well-defined thresholds are often nonexistent for host-parasite systems with more nuanced transmission structures (Getz & Pickering 1983). Complications include freeliving parasite stages, endangered hosts sharing parasites with abundant reservoir populations, and systems with frequencydependent transmission (Lafferty & Gerber 2002; Lafferty et al. 2015). Consequently, managers are tasked with mitigating wildlife disease in systems of varying complexity. Yet, the elimination of harmful parasites remains elusive due to the logistical challenges of reaching adequate proportions of wildlife, limited monetary and veterinary resources, and insufficient understanding of the numerous drivers underlying host disease state. Environmental, immunological, behavioural, demographic, physiological, and molecular mechanisms contribute to the expression of host disease phenotype (Fig. 1). Although many of these factors have been reviewed elsewhere, a comprehensive understanding of molecular diversity in the context of wildlife disease is lacking. In many studies, molecular diversity is considered synonymous with genetic diversity, but this fails to consider 2 additional components critical to proper immune functioning in hosts: epigenetic gene regulation and commensal microbial communities. We reviewed recent advances in understanding the molecular underpinnings of wildlife disease and examined how molecular methods can inform the management of disease dynamics operating across scales. We considered numerous examples to highlight questions that can be addressed with each molecular data type (i.e., parasite genetics, host genetics, epigenetic gene regulation, and commensal microbial variation). Two pathogens serve as our primary examples: devil facial tumour disease (DFTD) in Tasmanian devils (Sarcophilus harrisii) and chytridiomycosis in globally distributed amphibians (Table 1). These diseases lie at the frontier of applying an integrative molecular approach to wildlife disease, and demonstrate the numerous insights that can be gleaned from adopting these methods. Genetic Analyses of Wildlife Disease Abstract: Pathogens pose serious threats to human health, agricultural investment, and biodiversity conservation through the emergence of zoonoses, spillover to domestic livestock, and epizootic outbreaks. As such, wildlife managers are often tasked with mitigating the negative effects of disease. Yet, parasites form a major component of biodiversity that often persist. This is due to the logistical challenges of implementing management strategies and to insufficient understanding of host-parasite dynamics. We advocate for an inclusive understanding of molecular diversity in driving parasite infection and variable host disease states in wildlife systems. More specifically, we examine the roles of genetic, epigenetic, and commensal microbial variation in disease pathogenesis. These include mechanisms underlying parasite virulence and host resistance and tolerance, and the development, regulation, and parasite subversion of immune pathways, among other processes. Case studies of devil facial tumour disease in Tasmanian devils (Sarcophilus harrisii) and chytridiomycosis in globally distributed amphibians exemplify the broad range of questions that can be addressed by examining different facets of molecular diversity. For particularly complex systems, integrative molecular analyses present a promising frontier that can provide critical insights necessary to elucidate disease dynamics operating across scales. These insights enable more accurate risk assessment, reconstruction of transmission pathways, discernment of optimal intervention strategies, and development of more effective and ecologically sound treatments that minimize damage to the host population and environment. Such measures are crucial when mitigating threats posed by wildlife diseases to humans, domestic animals, and species of conservation concern. Figure 1. Factors affecting host disease state. Though presented as discrete categories, factors and subfactors often co-occur and interact to form a complex web of connections driving host disease state across scales. See examples in Supporting Information for more information on factors, subfactors, and interactions.

RkJQdWJsaXNoZXIy OTc5MDU=